Streetbeat News

CNTMF

Cansortium Inc

Industry

Medicinal and Botanical Manufacturing

Open

0.10

Mkt cap

32M

Volume

60K

High

0.10

P/E Ratio

-2.42

52-wk high

0.29

Low

0.10

Div yield

N/A

52-wk low

0.08

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

The article provides a detailed list of cannabis stock gainers and losers for February 5, 2024, highlighting significant movements in the market. Notable gainers include Tony G Co-Investment and Maple Leaf Green World, with increases of 81.16% and 45.45% respectively. On the losing end, EVIO led with a 99% decrease. Major US-listed companies mentioned include Eastside Distilling, Neptune Wellness Solutions, Village Farms International, Scotts Miracle-Gro, GrowGeneration, Innovative Industrial Properties, Canopy Growth, Tilray Brands, and Urban-gro.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 2, 2024, with notable gainers including Tony G Co-Investment, Global Hemp Group, and Khiron Life Sciences. On the downside, Global Compliance, MJ Holdings, and Rocky Mountain High were among the top losers. Neptune Wellness Solutions, Eastside Distilling, Canopy Growth, cbdMD, Corbus Pharmaceuticals, Tilray Brands, and Cronos Group were notable companies listed on major exchanges that saw price changes.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 1, 2024, with notable gainers including EVIO, Australis Capital, and OrganiGram Holdings, among others. EVIO led with a 9900.00% increase. On the downside, Rhinomed, Khiron Life Sciences, and Item 9 Labs were among the top losers. This reflects a volatile day in the cannabis sector, impacting several US-listed companies such as OrganiGram Holdings (OGI), Psychemedics (PMD), Cronos Group (CRON), Tilray Brands (TLRY), Canopy Growth (CGC), Eastside Distilling (EAST), 22nd Century Group (XXII), Greenlane Holdings (GNLN), SNDL Inc. (SNDL), and Aurora Cannabis (ACB).

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various marijuana stocks on January 29, 2024. Notable gainers include CordovaCann, Blueberries Medical, and 1933 Industries, with increases of 26.53%, 26.14%, and 15.88% respectively. Psychemedics, 4Front Ventures, and Canopy Growth also saw gains. On the losing side, EVIO plummeted by 99%, while Global Hemp Group and Corbus Pharmaceuticals experienced significant drops of 45.30% and 34.93%. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 24, 2024. Notable gainers included Global Hemp Group, Target Group, and Item 9 Labs, with increases of 68.40%, 47.06%, and 14.29% respectively. Trulieve Cannabis and MJ Holdings also saw gains over 11%. Corbus Pharmaceuticals and Neptune Wellness Solutions were among the NASDAQ-listed gainers. Conversely, MedMen Enterprises and EVIO suffered dramatic losses, closing down 99.99% and 98.00%. Other notable losers included Khiron Life Sciences and Cara Therapeutics. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.